Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Triglyceride-lowering Therapy With Pemafibrate for Prevention of Atherosclerotic Cardiovascular Disease in Patients With Symptomatic Intracranial Artery Stenosis: a Multi-center, Open-label, Randomized Controlled Trial (PPAR-ICAS)

NCT07562178 is registered in ClinicalTrials.gov with Tokyo Women's Medical University as lead sponsor.

NCT NCT07562178
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07562178 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Triglyceride-lowering Therapy With Pemafibrate for Prevention of Atherosclerotic Cardiovascular Disease in Patients With Symptomatic Intracranial Artery Stenosis: a Multi-center, Open-label, Randomized Controlled Trial (PPAR-ICAS)
Lead sponsor
Tokyo Women's Medical University
Phase
Not applicable
Overall status
Recruiting
Start date
May 26, 2026
Completion date
December 31, 2028
Enrollment
270 (estimated)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

hypertriglyceridaemia, intracranial atherosclerotic disease (icad), stroke (cva) or tia